DRUG Dividend History & Analysis | 0% Yield
DRUG has a dividend yield of 0% and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| ABBV | 376,277 M | 3.18% | 8.74% |
| GILD | 139,926 M | 2.82% | 5.69% |
| AMGN | 152,814 M | 3.29% | 4.45% |
| HLN | 43,525 M | 1.86% | 2.56% |
| BIOG-B | 1,131 M | 1.87% | 1.82% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BIOG-B | 1,131 M | 20.4% | 95.9% |
| GRFS | 8,687 M | 50.6% | 60.7% |
| SECARE | 676 M | 10.4% | 100% |
| AMGN | 152,814 M | 7.06% | 100% |
| ABBV | 376,277 M | 5.61% | 100% |
Similar Stocks with Attractive Dividends - Compare DRUG Dividends with its Peer-Group
3.18% Yield
3.29% Yield
2.82% Yield
1.76% Yield
DRUG Dividend History: as of September 2025
No dividends paid yet.DRUG Dividend FAQ
Bright Minds Biosciences Inc. (NASDAQ:DRUG) is a biotechnology company focused on developing therapeutics for severe and life-altering diseases. The companys portfolio includes selective 5-HT receptor agonists targeting epilepsy, pain, and neuropsychiatry. With a pipeline that includes BMB-101, which has completed Phase 1 trials for an undisclosed seizure disorder, and other candidates like BMB-201 and BMB-202, the company is positioned for potential growth in the biotechnology sector.
What is the Dividend Yield of DRUG?
As of September 2025, DRUG`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 48.75.Does DRUG pay a dividend?
As of September 2025 DRUG does not pay a dividend.How often does DRUG pay dividends?
Over the last 12 months, DRUG has issued dividend payments.Will DRUG pay dividends in 2025?
The next Ex-Dividend date for Bright Minds Biosciences (DRUG) is currently unknown.What is the next Ex-Dividend Date for DRUG?
The next Ex-Dividend date for Bright Minds Biosciences (DRUG) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of DRUG?
DRUG's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of DRUG?
DRUG's 5-Year Yield on Cost is -%. If you bought DRUG's shares at 27.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of DRUG?
DRUG Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does DRUG have a good Dividend Yield?
DRUG`s 0.00% Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of DRUG?
The Dividend Payout Ratio of DRUG is unknown.What is the Dividend Rating of DRUG?
DRUG`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-08-15 11:48